A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT06709131 · SUSPENDED

Trial details

NCT number: NCT06709131
Sponsor: He Huang
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Acute Myeloid Leukemia(AML)

Start date: 2025-01-08
Primary completion: 2025-08-17
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.